Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability.

[1]  Christian Gilissen,et al.  A de novo paradigm for mental retardation , 2010, Nature Genetics.

[2]  H. Ropers,et al.  Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes , 2010, Nature Genetics.

[3]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[4]  Alexander R. Griffing,et al.  Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. , 2010, American journal of human genetics.

[5]  H. Ropers.  Genetics of early onset cognitive impairment. , 2010, Annual review of genomics and human genetics.

[6]  John B. Vincent,et al.  Citation for Published Item: Use Policy the Genetic Basis of Non-syndromic Intellectual Disability: a Review , 2022 .

[7]  P. Shannon,et al.  Analysis of Genetic Inheritance in a Family Quartet by Whole-Genome Sequencing , 2010, Science.

[8]  Marie-Pierre Dubé,et al.  De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia , 2010, Proceedings of the National Academy of Sciences.

[9]  E. Gouaux,et al.  X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor , 2009, Nature.

[10]  N. Hirokawa,et al.  Kinesin superfamily motor proteins and intracellular transport , 2009, Nature Reviews Molecular Cell Biology.

[11]  R. Malinow,et al.  NMDA Receptor Phosphorylation at a Site Affected in Schizophrenia Controls Synaptic and Behavioral Plasticity , 2009, The Journal of Neuroscience.

[12]  R. Malinow,et al.  The Rho-linked mental retardation protein oligophrenin-1 controls synapse maturation and plasticity by stabilizing AMPA receptors. , 2009, Genes & development.

[13]  E. Fombonne,et al.  De novo STXBP1 mutations in mental retardation and nonsyndromic epilepsy , 2009, Annals of neurology.

[14]  R. Huganir,et al.  Regulation of AMPA receptor extrasynaptic insertion by 4.1N, phosphorylation and palmitoylation , 2009, Nature Neuroscience.

[15]  Laurent Mottron,et al.  Novel de novo SHANK3 mutation in autistic patients , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[16]  Dawen Cai,et al.  Mammalian Kinesin-3 Motors Are Dimeric In Vivo and Move by Processive Motility upon Release of Autoinhibition , 2009, PLoS biology.

[17]  Roberto Malinow,et al.  Synaptic AMPA Receptor Plasticity and Behavior , 2009, Neuron.

[18]  A. Addington,et al.  Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. , 2009, The New England journal of medicine.

[19]  R. Nicoll,et al.  Differential trafficking of AMPA and NMDA receptors by SAP102 and PSD-95 underlies synapse development , 2008, Proceedings of the National Academy of Sciences.

[20]  K. Williams,et al.  The Pore Region of N-Methyl-d-aspartate Receptors Differentially Influences Stimulation and Block by Spermine , 2008, Journal of Pharmacology and Experimental Therapeutics.

[21]  J. Zhu,et al.  Ras Signaling Mechanisms Underlying Impaired GluR1-Dependent Plasticity Associated with Fragile X Syndrome , 2008, The Journal of Neuroscience.

[22]  P. Curatolo,et al.  Deletion 2q37: An Identifiable Clinical Syndrome With Mental Retardation and Autism , 2008, Journal of child neurology.

[23]  Tao Wang,et al.  Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humans , 2007, Proceedings of the National Academy of Sciences.

[24]  R. Huganir,et al.  The cell biology of synaptic plasticity: AMPA receptor trafficking. , 2007, Annual review of cell and developmental biology.

[25]  Benjamin R. Rost,et al.  A defect in the ionotropic glutamate receptor 6 gene (GRIK2) is associated with autosomal recessive mental retardation. , 2007, American journal of human genetics.

[26]  S. Lipton,et al.  S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding , 2007, Cell Death and Differentiation.

[27]  Steven Finkbeiner,et al.  NMDA and AMPA receptors: old channels, new tricks , 2007, Trends in Neurosciences.

[28]  S. Grant,et al.  The role of neuronal complexes in human X-linked brain diseases. , 2007, American journal of human genetics.

[29]  Anushya Muruganujan,et al.  Applications for protein sequence–function evolution data: mRNA/protein expression analysis and coding SNP scoring tools , 2006, Nucleic Acids Res..

[30]  Yasuko Nakamura,et al.  Direct interaction of post‐synaptic density‐95/Dlg/ZO‐1 domain‐containing synaptic molecule Shank3 with GluR1 α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid receptor , 2006, Journal of neurochemistry.

[31]  S. Grant,et al.  Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome , 2006, Journal of neurochemistry.

[32]  R. Huganir,et al.  SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Macdonald,et al.  Paradox of Ca2+ signaling, cell death and stroke , 2006, Trends in Neurosciences.

[34]  J. Lerma.  Kainate receptor physiology. , 2006, Current opinion in pharmacology.

[35]  Eckart D Gundelfinger,et al.  An Architectural Framework That May Lie at the Core of the Postsynaptic Density , 2006, Science.

[36]  S. Grant,et al.  The proteomes of neurotransmitter receptor complexes form modular networks with distributed functionality underlying plasticity and behaviour , 2006, Molecular systems biology.

[37]  Torsten Schwede,et al.  The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling , 2006, Bioinform..

[38]  T. Schachtman,et al.  The role of metabotropic glutamate receptor 5 in learning and memory processes. , 2005, Drug news & perspectives.

[39]  H. Adesnik,et al.  Stargazin modulates AMPA receptor gating and trafficking by distinct domains , 2005, Nature.

[40]  P. Worley,et al.  Shank Expression Is Sufficient to Induce Functional Dendritic Spine Synapses in Aspiny Neurons , 2005, The Journal of Neuroscience.

[41]  D. Muller,et al.  The Mental Retardation Protein PAK3 Contributes to Synapse Formation and Plasticity in Hippocampus , 2004, The Journal of Neuroscience.

[42]  R. Huganir,et al.  AMPA Receptor-Dependent Clustering of Synaptic NMDA Receptors Is Mediated by Stargazin and NR2A/B in Spinal Neurons and Hippocampal Interneurons , 2004, Neuron.

[43]  S. Eom,et al.  An intramolecular interaction between the FHA domain and a coiled coil negatively regulates the kinesin motor KIF1A , 2004, The EMBO journal.

[44]  Joe Z Tsien,et al.  Inducible and Reversible NR1 Knockout Reveals Crucial Role of the NMDA Receptor in Preserving Remote Memories in the Brain , 2004, Neuron.

[45]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[46]  R. Weinberg,et al.  Association of the Kinesin Motor KIF1A with the Multimodular Protein Liprin-α* , 2003, The Journal of Biological Chemistry.

[47]  Eunjoon Kim,et al.  Characterization of the Movement of the Kinesin Motor KIF1A in Living Cultured Neurons* 210 , 2003, The Journal of Biological Chemistry.

[48]  N. Hirokawa,et al.  Charcot-Marie-Tooth Disease Type 2A Caused by Mutation in a Microtubule Motor KIF1Bβ , 2001, Cell.

[49]  Warren C. Lathe,et al.  Prediction of deleterious human alleles. , 2001, Human molecular genetics.

[50]  Dane M. Chetkovich,et al.  Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms , 2000, Nature.

[51]  Hsiao-Wen Chen,et al.  Unusual spectral energy distribution of a galaxy previously reported to be at redshift 6.68 , 2000, Nature.

[52]  R. Huganir,et al.  Regulation of AMPA Receptor GluR1 Subunit Surface Expression by a 4.1N-Linked Actin Cytoskeletal Association , 2000, The Journal of Neuroscience.

[53]  Marc G Caron,et al.  Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia , 1999, Cell.

[54]  N. Hirokawa,et al.  Defect in Synaptic Vesicle Precursor Transport and Neuronal Cell Death in KIF1A Motor Protein–deficient Mice , 1998, The Journal of cell biology.

[55]  J. Connor,et al.  Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death , 1994, Neuron.

[56]  T. Schwede,et al.  Protein structure homology modeling using SWISS-MODEL workspace , 2008, Nature Protocols.

[57]  Thomas Bourgeron,et al.  Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders , 2007, Nature Genetics.

[58]  N. Hirokawa,et al.  Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. , 2001, Cell.